Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Small-molecule displacement of a cryptic degron causes conditional protein degradation

Abstract

The ability to rapidly regulate the functions of specific proteins in living cells is a valuable tool for biological research. Here we describe a new technique by which the degradation of a specific protein is induced by a small molecule. A protein of interest is fused to a ligand-induced degradation (LID) domain, resulting in the expression of a stable and functional fusion protein. The LID domain is comprised of the FK506- and rapamycin-binding protein (FKBP) and a 19-amino-acid degron fused to the C terminus of FKBP. In the absence of the small molecule Shield-1, the degron is bound to the FKBP fusion protein and the protein is stable. When present, Shield-1 binds tightly to FKBP, displacing the degron and inducing rapid and processive degradation of the LID domain and any fused partner protein. Structure-function studies of the 19-residue peptide showed that a 4-amino-acid sequence within the peptide is responsible for degradation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Two strategies for ligand-regulated protein stability.
Figure 2: Characterization of the LID domain.
Figure 3: NMR analysis of FKBP and the LID domain.
Figure 4: Characterization of the 19-residue peptide degron.
Figure 5: LID domain regulates transcription factors.
Figure 6: Shield-1 can simultaneously stabilize and destabilize specific targets.

Similar content being viewed by others

Accession codes

Accessions

Protein Data Bank

References

  1. Furth, P.A. et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. USA 91, 9302–9306 (1994).

    Article  CAS  Google Scholar 

  2. Ryding, A.D.S., Sharp, M.G.F. & Mullins, J.J. Conditional transgenic technologies. J. Endocrinol. 171, 1–14 (2001).

    Article  CAS  Google Scholar 

  3. Banaszynski, L.A. & Wandless, T.J. Conditional control of protein function. Chem. Biol. 13, 11–21 (2006).

    Article  CAS  Google Scholar 

  4. Raina, K. & Crews, C.M. Chemical inducers of targeted protein degradation. J. Biol. Chem. 285, 11057–11060 (2010).

    Article  CAS  Google Scholar 

  5. Zhou, P., Bogacki, R., McReynolds, L. & Howley, P.M. Harnessing the ubiquitination machinery to target the degradation of specific cellular proteins. Mol. Cell 6, 751–756 (2000).

    Article  CAS  Google Scholar 

  6. Gosink, M.M. & Vierstra, R.D. Redirecting the specificity of ubiquitination by modifying ubiquitin-conjugating enzymes. Proc. Natl. Acad. Sci. USA 92, 9117–9121 (1995).

    Article  CAS  Google Scholar 

  7. Matsuzawa, S., Cuddy, M., Fukushima, T. & Reed, J.C. Method for targeting protein destruction by using a ubiquitin-independent, proteasome-mediated degradation pathway. Proc. Natl. Acad. Sci. USA 102, 14982–14987 (2005).

    Article  CAS  Google Scholar 

  8. Sakamoto, K.M. et al. Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation. Proc. Natl. Acad. Sci. USA 98, 8554–8559 (2001).

    Article  CAS  Google Scholar 

  9. Nishimura, K., Fukagawa, T., Takisawa, H., Kakimoto, T. & Kanemaki, M. An auxin-based degron system for the rapid depletion of proteins in nonplant cells. Nat. Methods 6, 917–922 (2009).

    Article  CAS  Google Scholar 

  10. Banaszynski, L.A., Chen, L.C., Maynard-Smith, L.A., Ooi, A.G.L. & Wandless, T.J. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell 126, 995–1004 (2006).

    Article  CAS  Google Scholar 

  11. Iwamoto, M., Björklund, T., Lundberg, C., Kirik, D. & Wandless, T.J. A general chemical method to regulate protein instability in the mammalian central nervous system. Chem. Biol. 17, 981–988 (2010).

    Article  CAS  Google Scholar 

  12. Harding, M.W., Galat, A., Uehling, D.E. & Schreiber, S.L. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341, 758–760 (1989).

    Article  CAS  Google Scholar 

  13. Gilon, T., Chomsky, O. & Kulka, R.G. Degradation signals for ubiquitin system proteolysis in Saccharomyces cerevisiae. EMBO J. 17, 2759–2766 (1998).

    Article  CAS  Google Scholar 

  14. Glotzer, M., Murray, A.W. & Kirschner, M.W. Cyclin is degraded by the ubiquitin pathway. Nature 349, 132–138 (1991).

    Article  CAS  Google Scholar 

  15. Lawson, T.G. et al. Identification and characterization of a protein destruction signal in the encephalomyocarditis virus 3C protease. J. Biol. Chem. 274, 9871–9880 (1999).

    Article  CAS  Google Scholar 

  16. Albers, M.W., Walsh, C.T. & Schreiber, S.L. Substrate specificity for the human rotamase FKBP: a view of FK506 and rapamycin as leucine-(twisted amide)-proline mimics. J. Org. Chem. 55, 4984–4986 (1990).

    Article  CAS  Google Scholar 

  17. Cameron, A.M. et al. FKBP12 binds the inositol 1,4,5-trisphosphate receptor at leucine-proline (1400–1401) and anchors calcineurin to this FK506-like domain. J. Biol. Chem. 272, 27582–27588 (1997).

    Article  CAS  Google Scholar 

  18. Yang, W. et al. Investigating protein-ligand interactions with a mutant FKBP possessing a designed specificity pocket. J. Med. Chem. 43, 1135–1142 (2000).

    Article  CAS  Google Scholar 

  19. Grimley, J.S., Chen, D.A., Banaszynski, L.A. & Wandless, T.J. Synthesis and analysis of stabilizing ligands for FKBP-derived destabilizing domains. Bioorg. Med. Chem. Lett. 18, 759–761 (2008).

    Article  CAS  Google Scholar 

  20. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).

    Article  CAS  Google Scholar 

  21. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).

    Article  CAS  Google Scholar 

  22. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).

    Article  CAS  Google Scholar 

  23. Wernig, M. et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318–324 (2007).

    Article  CAS  Google Scholar 

  24. Yoshimizu, T. et al. Germline-specific expression of the Oct-4/green fluorescent protein (GFP) transgene in mice. Dev. Growth Differ. 41, 675–684 (1999).

    Article  CAS  Google Scholar 

  25. Theriot, J.A. & Mitchison, T.J. Actin microfilament dynamics in locomoting cells. Nature 352, 126–131 (1991).

    Article  CAS  Google Scholar 

  26. Clackson, T. et al. Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity. Proc. Natl. Acad. Sci. USA 95, 10437–10442 (1998).

    Article  CAS  Google Scholar 

  27. Holt, D.A. et al. Design, synthesis, and kinetic evaluation of high-affinity FKBP ligands and the X-ray crystal structures of their complexes with FKBP12. J. Am. Chem. Soc. 115, 9925–9938 (1993).

    Article  CAS  Google Scholar 

  28. Delaglio, F. et al. NMRPipe—a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277–293 (1995).

    Article  CAS  Google Scholar 

  29. Garrett, D.S., Seok, Y.J., Peterofsky, A., Clore, G.M. & Gronenborn, A.M. Identification by NMR of the binding surface for the histidine-containing phosphocarrier protein HPr on the N-terminal domain of enzyme I of the Escherichia coli phosphotransferase system. Biochemistry 36, 4393–4398 (1997).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This research was supported by the US National Institutes of Health (GM073046). K.M.B. gratefully acknowledges the support of a Human Frontiers Science Program fellowship. C.W.L. and the Stanford Magnetic Resonance Laboratory are supported in part by the Stanford University School of Medicine. We would like to thank J. Lee and M. Verdoes for technical assistance.

Author information

Authors and Affiliations

Authors

Contributions

K.M.B., L.-c.C. and T.J.W. designed the research. K.M.B. and L.-c.C. performed and analyzed the biological experiments. K.M.B. and C.W.L. performed and analyzed the NMR experiments. K.M.B. and T.J.W. wrote the manuscript.

Corresponding author

Correspondence to Thomas J Wandless.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Methods and Supplementary Results (PDF 1236 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bonger, K., Chen, Lc., Liu, C. et al. Small-molecule displacement of a cryptic degron causes conditional protein degradation. Nat Chem Biol 7, 531–537 (2011). https://doi.org/10.1038/nchembio.598

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nchembio.598

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing